33 results
424B5
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
22 Jan 24
Prospectus supplement for primary offering
5:27pm
with the rules and regulations of The Nasdaq Stock Market LLC, or Nasdaq, we may comply with home country governance requirements and certain exemptions … thereunder rather than complying with Nasdaq corporate governance standards. We may choose to take advantage of the following exemptions afforded to foreign
6-K
EX-99.1
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
20 Dec 23
Current report (foreign)
4:06pm
an agent of the Company
Power to appoint an attorney or authorised signatory of the Company
Borrowing Powers
Corporate Governance
Meetings of Directors … shall establish an audit committee, a compensation committee and a nominating and corporate governance committee. Each of these committees shall
424B3
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
20 Dec 23
Prospectus supplement
4:03pm
, or Nasdaq, we may comply with home country governance requirements and certain exemptions thereunder rather than complying with Nasdaq corporate … governance standards. We may choose to take advantage of the following exemptions afforded to foreign private issuers:
Exemption from filing quarterly
F-3
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
5 Dec 23
Shelf registration (foreign)
4:06pm
, in accordance with the rules and regulations of The Nasdaq Stock Market LLC, or Nasdaq, we may comply with home country governance requirements … and certain exemptions thereunder rather than complying with Nasdaq corporate governance standards. We may choose to take advantage of the following
6-K
EX-99.1
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
8 Nov 23
Current report (foreign)
4:11pm
will seek re-election at the Meeting.
The Company’s corporate governance and nominating committee recommends, and the Board of Directors concurs
6-K
EX-99.4
l7l r1dus9jm
8 Nov 23
Current report (foreign)
4:11pm
6-K
2cx n3zf7l9
4 Oct 23
Current report (foreign)
7:24am
424B3
h29874p tyryl0
31 Mar 23
Prospectus supplement
4:04pm
424B3
419wvl
2 Dec 22
Prospectus supplement
4:17pm
F-1
imgfmu
18 Nov 22
Registration statement (foreign)
5:39pm
20-F
w2f7dtc5
12 Aug 22
Annual report (foreign)
4:20pm
6-K
EX-99.1
e5ywdnoqory5as03 pfl
26 Jul 22
Current report (foreign)
7:36am
6-K
EX-99.2
i8znmv1jy8tm7sg2c9
26 Jul 22
Current report (foreign)
7:36am
6-K
62nl uqi82q3xpz
26 Jul 22
Current report (foreign)
7:36am
6-K
EX-99.3
wh78bpsvq9uwvh9
26 Jul 22
Current report (foreign)
7:36am
424B4
4flsxnqb8b6svo
21 Jul 22
Prospectus supplement with pricing info
10:01am
FWP
zbfj5poozc7ye
30 Jun 22
Free writing prospectus
9:04pm
FWP
nzgu48phao3l 7pzpuml
30 Jun 22
Free writing prospectus
1:29pm
F-1/A
4az8qh
24 Jun 22
Registration statement (foreign) (amended)
9:47pm